Clinical Trial Update: Mechanisms of Weight Loss With SGLT2 Inhibition [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining mechanisms of weight loss associated with SGLT2 inhibitors in adults with type 2 diabetes and overweight/obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Type 2 Diabetes, Overweight | Phase 4 | Status: COMPLETED | Results posted: 2018-08-03